Public Comment on Draft Research Plan: Statin Use for Primary Prevention of Cardiovascular Disease in Adults| United States Preventive Services Taskforce

Opportunity for Public Comment | United States Preventive Services Taskforce

Draft Research Plan: Statin Use for Primary Prevention of CVD

Public Comment on Draft Research Plan: Statin Use for Primary Prevention of Cardiovascular Disease in Adults The U.S. Preventive Services Task Force posted today a draft research plan on statin use for primary prevention of cardiovascular disease in adults. The draft research plan is available for review and public comment from July 9, 2020 through August 5, 2020. To review the draft research plan and submit comments, go here. This Draft Research Plan Is Open to Public Comments

COMMENTING DETAILS

Commenting Window: 7/9/20 - 8/5/20 Any visitor to the Task Force website can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences. Learn more about the process.

WHERE WE ARE IN THE PROCESS

Draft Research Plan Final Research Plan Draft Recommendation Statement / Draft Evidence Review Final Recommendation Statement / Evidence Summary